Legend Biotech Ownership 2024 | Who Owns Legend Biotech Now?
Institutional Ownership
4.97%
Insider Ownership
1.31%
Retail Ownership
93.72%
Institutional Holders
54.00
Legend Biotech Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 9.68% | 0.05% | 17,621,599 | 1,474,567 | 9.13% | 780,460,639 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.31% | 0.06% | 11,489,275 | 540,155 | 4.93% | 508,861,000 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 4.12% | 4.40% | 7,506,934 | 645,837 | 9.41% | 332,482,107 | Jun 30, 2024 |
| HHLR ADVISORS, LTD. | 3.65% | 7.25% | 6,636,496 | 651,946 | 10.89% | 293,930,408 | Jun 30, 2024 |
| BLACKROCK INC. | 3.14% | 0.01% | 5,721,277 | 337,247 | 6.26% | 253,395,359 | Jun 30, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2.62% | 1.04% | 4,772,209 | 2,532,435 | 113.07% | 211,361,147 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.54% | 0.02% | 2,809,368 | 194,945 | 7.46% | 124,426,908 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 1.30% | 0.06% | 2,359,056 | 345,044 | 17.13% | 104,466,876 | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 1.19% | 0.02% | 2,162,711 | -18,363 | -0.84% | 95,786,470 | Jun 30, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.08% | 0.03% | 1,960,709 | 69,913 | 3.70% | 86,839,800 | Jun 30, 2024 |
| BRAIDWELL LP | 0.92% | 2.32% | 1,669,720 | 425,925 | 34.24% | 73,951,899 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.91% | 0.03% | 1,658,681 | 1,287,590 | 346.97% | 73,462,981 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.85% | 0.16% | 1,541,345 | 4,285 | 0.28% | 68,266,170,000 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 0.66% | 2.04% | 1,203,308 | -778,698 | -39.29% | 53,294,511 | Jun 30, 2024 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 0.64% | 0.82% | 1,173,766 | 15,266 | 1.32% | 51,986,096 | Jun 30, 2024 |
| STATE STREET CORP | 0.62% | 0.00% | 1,135,487 | 87,485 | 8.35% | 50,290,719,000 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.60% | 0.02% | 1,087,849 | -25,309 | -2.27% | 48,180,832 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 0.58% | 0.56% | 1,062,734 | 15,995 | 1.53% | 47,068,489 | Jun 30, 2024 |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 0.56% | 9.86% | 1,022,780 | 270,845 | 36.02% | 45,298,926 | Jun 30, 2024 |
| JOHNSON & JOHNSON | 0.45% | 9.00% | 814,586 | - | - | 36,078,014 | Jun 30, 2024 |
Legend Biotech's largest institutional shareholder is FMR LLC, holding 9.68% of the company's total share outstanding, currently valued at $780.46M. The top 10 institutional shareholders own together 34.64% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 0.56% | 9.86% | 1,022,780 | 270,845 | 36.02% | 45,298,926 | Jun 30, 2024 |
| JOHNSON & JOHNSON | 0.45% | 9.00% | 814,586 | - | - | 36,078,014 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.09% | 8.64% | 154,665 | 154,665 | 100.00% | 6,850,113 | Jun 30, 2024 |
| HHLR ADVISORS, LTD. | 3.65% | 7.25% | 6,636,496 | 651,946 | 10.89% | 293,930,408 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.11% | 5.15% | 195,000 | 195,000 | 100.00% | 8,636,550 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.19% | 4.59% | 343,130 | 263,300 | 329.83% | 15,197,228 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 4.12% | 4.40% | 7,506,934 | 645,837 | 9.41% | 332,482,107 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 0.20% | 3.99% | 356,532 | 72,759 | 25.64% | 15,790,802 | Jun 30, 2024 |
| BRAIDWELL LP | 0.92% | 2.32% | 1,669,720 | 425,925 | 34.24% | 73,951,899 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 0.66% | 2.04% | 1,203,308 | -778,698 | -39.29% | 53,294,511 | Jun 30, 2024 |
| E FUND MANAGEMENT (HONG KONG) CO., LTD. | 0.03% | 1.59% | 58,426 | 1,374 | 2.41% | 2,588,000 | Jun 30, 2024 |
| OLD WELL PARTNERS, LLC | 0.02% | 1.42% | 29,301 | -12,700 | -30.24% | 1,297,741 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 0.33% | 1.40% | 600,000 | - | - | 26,574,000 | Jun 30, 2024 |
| DECHENG CAPITAL LLC | 0.05% | 1.34% | 98,558 | 12,195 | 14.12% | 4,365,134 | Jun 30, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2.62% | 1.04% | 4,772,209 | 2,532,435 | 113.07% | 211,361,147 | Jun 30, 2024 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 0.64% | 0.82% | 1,173,766 | 15,266 | 1.32% | 51,986,096 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.22% | 0.75% | 398,000 | -270,300 | -40.45% | 17,627,420 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.28% | 0.67% | 505,786 | 6,300 | 1.26% | 22,401,262 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 0.58% | 0.56% | 1,062,734 | 15,995 | 1.53% | 47,068,489 | Jun 30, 2024 |
| EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. | 0.04% | 0.55% | 71,079 | 1,820 | 2.63% | 3,146,667 | Jun 30, 2024 |
The largest Legend Biotech shareholder by % of total assets is MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC. The company owns 1.02M shares of Legend Biotech (LEGN), representing 9.86% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2.62% | 1.04% | 4,772,209 | 2,532,435 | 113.07% | 211,361,147 | Jun 30, 2024 |
| FMR LLC | 9.68% | 0.05% | 17,621,599 | 1,474,567 | 9.13% | 780,460,639 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.91% | 0.03% | 1,658,681 | 1,287,590 | 346.97% | 73,462,981 | Jun 30, 2024 |
| HHLR ADVISORS, LTD. | 3.65% | 7.25% | 6,636,496 | 651,946 | 10.89% | 293,930,408 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 4.12% | 4.40% | 7,506,934 | 645,837 | 9.41% | 332,482,107 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.36% | 0.01% | 657,387 | 563,668 | 601.44% | 29,115,670 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.31% | 0.06% | 11,489,275 | 540,155 | 4.93% | 508,861,000 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.25% | 0.04% | 451,965 | 451,965 | 100.00% | 20,017,530 | Jun 30, 2024 |
| BRAIDWELL LP | 0.92% | 2.32% | 1,669,720 | 425,925 | 34.24% | 73,951,899 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.37% | 0.01% | 667,990 | 357,582 | 115.20% | 29,585,277 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 1.30% | 0.06% | 2,359,056 | 345,044 | 17.13% | 104,466,876 | Jun 30, 2024 |
| BLACKROCK INC. | 3.14% | 0.01% | 5,721,277 | 337,247 | 6.26% | 253,395,359 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.17% | 0.04% | 304,520 | 304,520 | 100.00% | 13,487,192 | Jun 30, 2024 |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 0.56% | 9.86% | 1,022,780 | 270,845 | 36.02% | 45,298,926 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.19% | 4.59% | 343,130 | 263,300 | 329.83% | 15,197,228 | Jun 30, 2024 |
| MAGNETAR FINANCIAL LLC | 0.14% | 0.23% | 251,667 | 251,667 | 100.00% | 11,146,331 | Jun 30, 2024 |
| NORDEA INVESTMENT MANAGEMENT AB | 0.13% | 0.01% | 238,600 | 223,613 | 1492.05% | 10,584,296 | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 0.13% | 0.22% | 235,059 | 198,159 | 537.02% | 10,410,763 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.11% | 5.15% | 195,000 | 195,000 | 100.00% | 8,636,550 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.54% | 0.02% | 2,809,368 | 194,945 | 7.46% | 124,426,908 | Jun 30, 2024 |
As of Jun 30 2024, Legend Biotech's largest institutional buyer is WESTFIELD CAPITAL MANAGEMENT CO LP. The company purchased 2.53M stocks of LEGN, valued at $211.36M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | - | - | - | -2,385,960 | -100.00% | - | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 0.66% | 2.04% | 1,203,308 | -778,698 | -39.29% | 53,294,511 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | - | - | - | -761,626 | -100.00% | - | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | - | - | - | -734,293 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.05% | 0.00% | 86,410 | -466,003 | -84.36% | 3,827,099 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | - | - | - | -366,388 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.03% | 0.03% | 50,000 | -314,200 | -86.27% | 2,214,500 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.22% | 0.75% | 398,000 | -270,300 | -40.45% | 17,627,420 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | - | - | - | -228,251 | -100.00% | - | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.06% | 0.00% | 106,533 | -223,790 | -67.75% | 4,718,346 | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -162,742 | -100.00% | - | Jun 30, 2024 |
| ARDSLEY ADVISORY PARTNERS LP | - | - | - | -140,000 | -100.00% | - | Jun 30, 2024 |
| DUQUESNE FAMILY OFFICE LLC | - | - | - | -114,500 | -100.00% | - | Jun 30, 2024 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | 0.01% | 0.00% | 23,046 | -92,458 | -80.05% | 1,020,707 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.18% | 0.00% | 321,743 | -87,810 | -21.44% | 14,249,998 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.08% | 0.01% | 140,992 | -45,400 | -24.36% | 6,244,536 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | - | - | - | -44,653 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWATER ASSOCIATES, LP | 0.09% | 0.04% | 165,459 | -43,441 | -20.80% | 7,328,179 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.20% | 0.00% | 355,948 | -41,251 | -10.39% | 15,764,937 | Jun 30, 2024 |
As of Jun 30 2024, Legend Biotech's biggest institutional seller is CAPITAL WORLD INVESTORS. The company sold -2.39M shares of LEGN, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 0.25% | 0.04% | 451,965 | 451,965 | 100.00% | 20,017,530 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.17% | 0.04% | 304,520 | 304,520 | 100.00% | 13,487,192 | Jun 30, 2024 |
| MAGNETAR FINANCIAL LLC | 0.14% | 0.23% | 251,667 | 251,667 | 100.00% | 11,146,331 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.11% | 5.15% | 195,000 | 195,000 | 100.00% | 8,636,550 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.09% | 8.64% | 154,665 | 154,665 | 100.00% | 6,850,113 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.08% | 0.42% | 154,074 | 154,074 | 100.00% | 6,823,937 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.01% | 86,338 | 86,338 | 100.00% | 3,823,910 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.04% | 0.00% | 80,000 | 80,000 | 100.00% | 3,543,200 | Jun 30, 2024 |
| EMPIRE LIFE INVESTMENTS INC. | 0.03% | 0.16% | 56,320 | 56,320 | 100.00% | 2,494,413 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.02% | 0.03% | 29,905 | 29,905 | 100.00% | 1,324,492 | Jun 30, 2024 |
| POINT72 EUROPE (LONDON) LLP | 0.01% | 0.08% | 22,245 | 22,245 | 100.00% | 985,221 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.01% | 0.00% | 22,045 | 22,045 | 100.00% | 976,375 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.01% | 0.00% | 10,513 | 10,513 | 100.00% | 465,621 | Jun 30, 2024 |
| CIBC ASSET MANAGEMENT INC | 0.00% | 0.00% | 6,379 | 6,379 | 100.00% | 282,526 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.00% | 0.00% | 5,853 | 5,853 | 100.00% | 260,000 | Jun 30, 2024 |
| CREDIT AGRICOLE S A | 0.00% | 0.00% | 2,600 | 2,600 | 100.00% | 115,154 | Jun 30, 2024 |
| AM SQUARED LTD | 0.00% | 0.18% | 1,600 | 1,600 | 100.00% | 70,864 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.00% | 0.00% | 900 | 900 | 100.00% | 39,861 | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.00% | 0.00% | 654 | 654 | 100.00% | 28,966 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | 0.00% | 0.00% | 297 | 297 | 100.00% | 18,283 | Jun 30, 2024 |
Legend Biotech's largest new institutional shareholder by number of shares is BALYASNY ASSET MANAGEMENT L.P., purchased 451.96K shares, valued at $20.02M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | - | - | - | -2,385,960 | -100.00% | - | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | - | - | - | -761,626 | -100.00% | - | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | - | - | - | -734,293 | -100.00% | - | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | - | - | - | -366,388 | -100.00% | - | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | - | - | - | -228,251 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -162,742 | -100.00% | - | Jun 30, 2024 |
| ARDSLEY ADVISORY PARTNERS LP | - | - | - | -140,000 | -100.00% | - | Jun 30, 2024 |
| DUQUESNE FAMILY OFFICE LLC | - | - | - | -114,500 | -100.00% | - | Jun 30, 2024 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | - | - | - | -44,653 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -40,922 | -100.00% | - | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -40,239 | -100.00% | - | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | - | - | - | -36,385 | -100.00% | - | Jun 30, 2024 |
| KEYSTONE INVESTORS PTE LTD | - | - | - | -35,885 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -34,746 | -100.00% | - | Jun 30, 2024 |
| HAP TRADING, LLC | - | - | - | -32,600 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -27,700 | -100.00% | - | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -25,200 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -18,854 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -16,284 | -100.00% | - | Jun 30, 2024 |
| OLD MISSION CAPITAL LLC | - | - | - | -14,230 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -14,200 | -100.00% | - | Jun 30, 2024 |
| PARAMETRICA MANAGEMENT LTD | - | - | - | -11,800 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -9,959 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -9,941 | -100.00% | - | Jun 30, 2024 |
| E. OHMAN J:OR ASSET MANAGEMENT AB | - | - | - | -6,600 | -100.00% | - | Jun 30, 2024 |
| OBERWEIS ASSET MANAGEMENT INC/ | - | - | - | -6,000 | -100.00% | - | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -5,976 | -100.00% | - | Jun 30, 2024 |
| BAROMETER CAPITAL MANAGEMENT INC. | - | - | - | -5,238 | -100.00% | - | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | - | - | - | -4,827 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -4,570 | -100.00% | - | Jun 30, 2024 |
| INTECH INVESTMENT MANAGEMENT LLC | - | - | - | -4,226 | -100.00% | - | Jun 30, 2024 |
| IFM INVESTORS PTY LTD | - | - | - | -3,712 | -100.00% | - | Jun 30, 2024 |
| NOMURA HOLDINGS INC | - | - | - | -3,657 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS | - | - | - | -3,556 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -3,345 | -100.00% | - | Jun 30, 2024 |
| BI ASSET MANAGEMENT FONDSMAEGLERSELSKAB A/S | - | - | - | -3,318 | -100.00% | - | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -900 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -380 | -100.00% | - | Jun 30, 2024 |
Legend Biotech's largest sold out institutional shareholder by shares sold is CAPITAL WORLD INVESTORS, sold -2.39M shares, valued at -, as of undefined.
Legend Biotech Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price Growth Stock Fund, Inc. | 0.39% | 2,420,741 | 354,600 | 17.16% | Mar 31, 2024 |
| MFS SERIES TRUST IV | 0.39% | 1,339,933 | -4,598 | -0.34% | Feb 29, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.34% | 316,221 | - | - | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.32% | 1,073,925 | -297,758 | -21.71% | Mar 31, 2024 |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.23% | 80,600 | - | - | Mar 31, 2024 |
| Clough Global Equity Fund | 0.20% | 12,300 | - | - | Jan 31, 2024 |
| Tema ETF Trust | 0.16% | 6,978 | 2,278 | 48.47% | Feb 29, 2024 |
| MERIDIAN FUND INC | 0.15% | 355,015 | - | - | Mar 28, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.15% | 217,687 | 16,435 | 8.17% | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.14% | 1,200,000 | 200,000 | 20.00% | Jan 31, 2024 |
| BlackRock Health Sciences Trust | 0.13% | 32,098 | 121 | 0.38% | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.12% | 316,032 | 1,011 | 0.32% | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.11% | 1,250,809 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.11% | 301,500 | 114,000 | 60.80% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.11% | 3,030,177 | -127,249 | -4.03% | Feb 29, 2024 |
| Clough Funds Trust | 0.09% | 3,716 | - | - | Jan 31, 2023 |
| Federated Hermes Equity Funds | 0.08% | 1,620,775 | -83,554 | -4.90% | Jan 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.08% | 387,130 | -2,800 | -0.72% | Mar 31, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.07% | 42,997 | - | - | Feb 29, 2024 |
| Clough Global Opportunities Fund | 0.06% | 22,700 | - | - | Jan 31, 2024 |
| LORD ABBETT RESEARCH FUND INC | 0.06% | 53,910 | - | - | Feb 29, 2024 |
| SMALLCAP WORLD FUND INC | 0.04% | 3,148,299 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.04% | 2,870,010 | 694,300 | 31.91% | Feb 29, 2024 |
| T. Rowe Price Tax-Efficient Funds, Inc. | 0.03% | 3,200 | 700 | 28.00% | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.03% | 53,353 | -9,584 | -15.23% | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.03% | 59,143 | - | - | Feb 29, 2024 |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.03% | 195,500 | 98,000 | 100.51% | Mar 31, 2024 |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 0.02% | 18,300 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.02% | 186,400 | -18,040 | -8.82% | Mar 31, 2024 |
| FIDELITY DESTINY PORTFOLIOS | 0.02% | 46,600 | -7,000 | -13.06% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.02% | 349,400 | 84,100 | 31.70% | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.02% | 58,927 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.01% | 14,296 | - | - | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.01% | 122,034 | - | - | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 157,900 | 1,000 | 0.64% | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 716,171 | 308,885 | 75.84% | Mar 31, 2024 |
| ALPS ETF Trust | 0.01% | 174,194 | - | - | Feb 29, 2024 |
| EMERGING MARKETS GROWTH FUND INC | 0.01% | 188,351 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 105,093 | - | - | Mar 28, 2024 |
| AMG FUNDS | 0.01% | 337,092 | 49,800 | 17.33% | Mar 28, 2024 |
| Humankind Benefit Corp | 0.01% | 230 | - | - | Dec 31, 2023 |
| AB CAP FUND, INC. | 0.01% | 347,433 | 11,219 | 3.34% | Jan 31, 2024 |
| MFS SERIES TRUST I | 0.01% | 171,060 | - | - | Feb 29, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.01% | 57,861 | - | - | Mar 31, 2024 |
| BARON SELECT FUNDS | 0.01% | 70,000 | -5,000 | -6.67% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.01% | 28,526 | 28,526 | - | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 19,970 | 310 | 1.58% | Feb 29, 2024 |
| Gabelli Healthcare & WellnessRx Trust | 0.01% | 720 | - | - | Dec 29, 2023 |
| OBERWEIS FUNDS | 0.01% | 6,000 | -10,000 | -62.50% | Mar 31, 2024 |
| FIDELITY PURITAN TRUST | 0.01% | 297,508 | -472,525 | -61.36% | Feb 29, 2024 |
| Bernstein Fund Inc | 0.01% | 48,550 | 16,740 | 52.62% | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 509,497 | 509,497 | - | Jan 31, 2024 |
| TOUCHSTONE STRATEGIC TRUST | 0.01% | 337,435 | 50,094 | 17.43% | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 19,560 | -2,083 | -9.62% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 41,308 | 17,754 | 75.38% | Mar 31, 2024 |
| FIDELITY CONTRAFUND | 0.00% | 245,500 | -607,848 | -71.23% | Mar 31, 2024 |
| HOMESTEAD FUNDS INC | 0.00% | 20,220 | -1,997 | -8.99% | Mar 31, 2024 |
| ETFis Series Trust I | 0.00% | 5,314 | 905 | 20.53% | Jan 31, 2024 |
| FIDELITY INVESTMENT TRUST | 0.00% | 734,227 | 255,044 | 53.22% | Jan 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 841,640 | 14,791 | 1.79% | Dec 31, 2023 |
| MFS VARIABLE INSURANCE TRUST | 0.00% | 83,980 | -306 | -0.36% | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 3,102 | 3,102 | - | Dec 31, 2023 |
| Columbia Funds Variable Series Trust II | 0.00% | 64,270 | -8,640 | -11.85% | Mar 31, 2024 |
| AMERICAN FUNDS DEVELOPING WORLD GROWTH & INCOME FUND | 0.00% | 41,654 | -6,083 | -12.74% | Feb 29, 2024 |
| Harbor ETF Trust | 0.00% | 7,479 | 2,852 | 61.64% | Jan 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 6,300 | - | - | Mar 28, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,151 | - | - | Mar 31, 2024 |
| Voya PARTNERS INC | 0.00% | 110,072 | 5,000 | 4.76% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 23,259 | 12,200 | 110.32% | Feb 29, 2024 |
| Global X Funds | 0.00% | 50,193 | - | - | Jan 31, 2024 |
| Krane Shares Trust | 0.00% | 19,628 | 362 | 1.88% | Dec 31, 2023 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 5,020 | -740 | -12.85% | Mar 31, 2024 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 6,989 | 873 | 14.27% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 814 | 29 | 3.69% | Jan 31, 2024 |
| MATTHEWS INTERNATIONAL FUNDS | 0.00% | 11,206 | 1,713 | 18.04% | Mar 31, 2024 |
| UBS FUNDS | 0.00% | 3,200 | - | - | Mar 31, 2024 |
| ALLSPRING VARIABLE TRUST | 0.00% | 398 | - | - | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 71,555 | 64,622 | 932.09% | Mar 28, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 780,108 | 264,849 | 51.40% | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 15,349 | 1,440 | 10.35% | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 17,949 | 2,700 | 17.71% | Mar 28, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 2,981 | 1 | 0.03% | Mar 31, 2024 |
| BLACKROCK SUSTAINABLE BALANCED FUND, INC. | 0.00% | 3,792 | - | - | Feb 29, 2024 |
| Nushares ETF Trust | 0.00% | 3,734 | - | - | Jan 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 65,834 | -12,044 | -15.47% | Jan 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 9,675 | 557 | 6.11% | Mar 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 93,935 | 1,094 | 1.18% | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 1,725 | - | - | Mar 28, 2024 |
| LORD ABBETT BOND DEBENTURE FUND INC | 0.00% | 426,613 | - | - | Mar 31, 2024 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.00% | 16,092 | -1,119 | -6.50% | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 22,869 | - | - | Feb 29, 2024 |
| Virtus Strategy Trust | 0.00% | 7,276 | - | - | Mar 28, 2024 |
| Guardian Variable Products Trust | 0.00% | 5,396 | 5,396 | - | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 1,160 | - | - | Jan 31, 2024 |
| Columbia Funds Series Trust II | 0.00% | 89,200 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 46,908 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,100 | - | - | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 2,995 | - | - | Feb 29, 2024 |
| ARTISAN PARTNERS FUNDS INC | 0.00% | 309,698 | -11,610 | -3.61% | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 60,754 | -7,467 | -10.95% | Jan 31, 2024 |
Legend Biotech's largest mutual fund holder by % of total assets is "T. Rowe Price Growth Stock Fund, Inc.", owning 2.42M shares, compromising 0.39% of its total assets.
Legend Biotech Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 54 | -74.41% |
| 31 Mar, 24 | 211 | -7.05% |
| 31 Dec, 23 | 227 | 5.09% |
| 30 Sep, 23 | 216 | 6.93% |
| 30 Jun, 23 | 202 | 18.82% |
| 31 Mar, 23 | 170 | -6.08% |
| 31 Dec, 22 | 181 | 7.10% |
| 30 Sep, 22 | 169 | 5.63% |
| 30 Jun, 22 | 160 | 7.38% |
| 31 Mar, 22 | 149 | 4.20% |
| 31 Dec, 21 | 143 | 55.43% |
| 30 Sep, 21 | 92 | -1.08% |
| 30 Jun, 21 | 93 | 27.40% |
| 31 Mar, 21 | 73 | 19.67% |
| 31 Dec, 20 | 61 | 22.00% |
| 30 Sep, 20 | 50 | -34.21% |
| 30 Jun, 20 | 76 | - |
As of 30 Jun 24, 54 institutions are holding Legend Biotech's shares, representing a decrease of -74.41% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 9,051,962 | -89.54% |
| 31 Mar, 24 | 86,578,978 | 0.79% |
| 31 Dec, 23 | 85,900,395 | -0.06% |
| 30 Sep, 23 | 85,954,399 | 1.67% |
| 30 Jun, 23 | 84,545,010 | 24.30% |
| 31 Mar, 23 | 68,016,398 | 6.39% |
| 31 Dec, 22 | 63,930,495 | 0.20% |
| 30 Sep, 22 | 63,801,103 | 21.07% |
| 30 Jun, 22 | 52,698,237 | 3.29% |
| 31 Mar, 22 | 51,017,433 | 1.64% |
| 31 Dec, 21 | 50,194,720 | 28.72% |
| 30 Sep, 21 | 38,996,206 | 37.68% |
| 30 Jun, 21 | 28,323,307 | 7.32% |
| 31 Mar, 21 | 26,391,132 | 3.72% |
| 31 Dec, 20 | 25,444,631 | 3.94% |
| 30 Sep, 20 | 24,479,709 | -0.54% |
| 30 Jun, 20 | 24,613,275 | - |
Legend Biotech (LEGN) has 9.05M shares outstanding as of 30 Jun 24, down -89.54% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 4.97% | 0.21% |
| 31 Mar, 24 | 49.17% | 8.08% |
| 31 Dec, 23 | 24.66% | 1.03% |
| 30 Sep, 23 | 48.97% | 1.87% |
| 30 Jun, 23 | 51.16% | 3.02% |
| 31 Mar, 23 | 41.16% | 2.55% |
| 31 Dec, 22 | 40.20% | 2.37% |
| 30 Sep, 22 | 41.19% | 3.56% |
| 30 Jun, 22 | 34.02% | 3.11% |
| 31 Mar, 22 | 33.05% | 2.82% |
| 31 Dec, 21 | 34.24% | 4.73% |
| 30 Sep, 21 | 26.90% | 6.43% |
| 30 Jun, 21 | 20.45% | 5.21% |
| 31 Mar, 21 | 19.82% | 5.36% |
| 31 Dec, 20 | 19.22% | 5.60% |
| 30 Sep, 20 | 18.52% | 3.55% |
| 30 Jun, 20 | 22.84% | - |
As of 30 Jun 24, Legend Biotech is held by 4.97% institutional shareholders, representing a 0.21% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 31 | -72.57% |
| 31 Mar, 24 | 113 | -13.08% |
| 31 Dec, 23 | 130 | 36.84% |
| 30 Sep, 23 | 95 | -12.04% |
| 30 Jun, 23 | 108 | 18.68% |
| 31 Mar, 23 | 91 | 2.25% |
| 31 Dec, 22 | 89 | -16.04% |
| 30 Sep, 22 | 106 | 17.78% |
| 30 Jun, 22 | 90 | -2.17% |
| 31 Mar, 22 | 92 | -14.81% |
| 31 Dec, 21 | 108 | 103.77% |
| 30 Sep, 21 | 53 | 1.92% |
| 30 Jun, 21 | 52 | 30.00% |
| 31 Mar, 21 | 40 | 11.11% |
| 31 Dec, 20 | 36 | 44.00% |
| 30 Sep, 20 | 25 | -67.11% |
| 30 Jun, 20 | 76 | - |
31 institutional shareholders have increased their position in LEGN stock as of 30 Jun 24 compared to 113 in the previous quarter (a -72.57% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -84.13% |
| 31 Mar, 24 | 63 | 6.78% |
| 31 Dec, 23 | 59 | -16.90% |
| 30 Sep, 23 | 71 | 7.58% |
| 30 Jun, 23 | 66 | 29.41% |
| 31 Mar, 23 | 51 | -13.56% |
| 31 Dec, 22 | 59 | 59.46% |
| 30 Sep, 22 | 37 | -24.49% |
| 30 Jun, 22 | 49 | 58.06% |
| 31 Mar, 22 | 31 | 40.91% |
| 31 Dec, 21 | 22 | 22.22% |
| 30 Sep, 21 | 18 | - |
| 30 Jun, 21 | 18 | 28.57% |
| 31 Mar, 21 | 14 | -12.50% |
| 31 Dec, 20 | 16 | -5.88% |
| 30 Sep, 20 | 17 | - |
| 30 Jun, 20 | - | - |
10 institutional shareholders have reduced their position in LEGN stock as of 30 Jun 24 compared to 63 in the previous quarter (a -84.13% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 54 | -74.41% | 9,051,962 | -89.54% | 4.97% | 0.21% | 31 | -72.57% | 10 | -84.13% |
| 31 Mar, 24 | 211 | -7.05% | 86,578,978 | 0.79% | 49.17% | 8.08% | 113 | -13.08% | 63 | 6.78% |
| 31 Dec, 23 | 227 | 5.09% | 85,900,395 | -0.06% | 24.66% | 1.03% | 130 | 36.84% | 59 | -16.90% |
| 30 Sep, 23 | 216 | 6.93% | 85,954,399 | 1.67% | 48.97% | 1.87% | 95 | -12.04% | 71 | 7.58% |
| 30 Jun, 23 | 202 | 18.82% | 84,545,010 | 24.30% | 51.16% | 3.02% | 108 | 18.68% | 66 | 29.41% |
| 31 Mar, 23 | 170 | -6.08% | 68,016,398 | 6.39% | 41.16% | 2.55% | 91 | 2.25% | 51 | -13.56% |
| 31 Dec, 22 | 181 | 7.10% | 63,930,495 | 0.20% | 40.20% | 2.37% | 89 | -16.04% | 59 | 59.46% |
| 30 Sep, 22 | 169 | 5.63% | 63,801,103 | 21.07% | 41.19% | 3.56% | 106 | 17.78% | 37 | -24.49% |
| 30 Jun, 22 | 160 | 7.38% | 52,698,237 | 3.29% | 34.02% | 3.11% | 90 | -2.17% | 49 | 58.06% |
| 31 Mar, 22 | 149 | 4.20% | 51,017,433 | 1.64% | 33.05% | 2.82% | 92 | -14.81% | 31 | 40.91% |
| 31 Dec, 21 | 143 | 55.43% | 50,194,720 | 28.72% | 34.24% | 4.73% | 108 | 103.77% | 22 | 22.22% |
| 30 Sep, 21 | 92 | -1.08% | 38,996,206 | 37.68% | 26.90% | 6.43% | 53 | 1.92% | 18 | - |
| 30 Jun, 21 | 93 | 27.40% | 28,323,307 | 7.32% | 20.45% | 5.21% | 52 | 30.00% | 18 | 28.57% |
| 31 Mar, 21 | 73 | 19.67% | 26,391,132 | 3.72% | 19.82% | 5.36% | 40 | 11.11% | 14 | -12.50% |
| 31 Dec, 20 | 61 | 22.00% | 25,444,631 | 3.94% | 19.22% | 5.60% | 36 | 44.00% | 16 | -5.88% |
| 30 Sep, 20 | 50 | -34.21% | 24,479,709 | -0.54% | 18.52% | 3.55% | 25 | -67.11% | 17 | - |
| 30 Jun, 20 | 76 | - | 24,613,275 | - | 22.84% | - | 76 | - | - | - |
Legend Biotech Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| AKRO | Akero Therapeutics, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| TVTX | Travere Therapeutics, Inc. |
| ALNY | Alnylam Pharmaceuticals, Inc. |
| ZLAB | Zai Lab Limited |
| TERN | Terns Pharmaceuticals, Inc. |
| ASND | Ascendis Pharma A/S |
| ACLX | Arcellx, Inc. |
| ETNB | 89bio, Inc. |
| PCVX | Vaxcyte, Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| MDGL | Madrigal Pharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
LEGN Ownership FAQ
Who Owns Legend Biotech?
Legend Biotech is owned by institutional shareholders (4.97%), insiders (1.31%), and public (93.72%). The largest institutional shareholder of Legend Biotech is FMR LLC (9.68% of total shares) and the top mutual fund owner is T. Rowe Price Growth Stock Fund, Inc. (0.39% of total shares).
Who are the major institutional shareholders of Legend Biotech?
Legend Biotech's major institutional shareholders are FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, L.P., HHLR ADVISORS, LTD., and BLACKROCK INC.. The top five shareholders own together 26.91% of the company's share outstanding.
How many Legend Biotech shareholders are there?
As of Jun 2024, there are 54 institutional shareholders of Legend Biotech.
What percentage of Legend Biotech is owned by FMR LLC?
FMR LLC owns 17.62M shares of Legend Biotech, representing 9.68% of the company's total shares outstanding, valued at $780.46M (as of Jun 2024).
What percentage of Legend Biotech is owned by PRICE T ROWE ASSOCIATES INC /MD/?
As of Jun 2024, PRICE T ROWE ASSOCIATES INC /MD/ holds 11.49M shares of Legend Biotech (LEGN), compromising 6.31% of the company, valued at $508.86M.
What percentage of Legend Biotech is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P is the third largest holder of Legend Biotech. The company owns 7.51M of the company's shares outstanding (worth $332.48M).